Ryan Daws

Ryan Daws is Obsidian’s Chief Financial Officer and Head of Business Development, a role in which he defines and drives the financial and corporate growth of the Company. Mr. Daws brings over 20 years of strong biotech operating and transactional experience combined with significant investment banking experience. Mr. Daws most recently served as a Managing Director in the Healthcare Investment Banking Group at Robert W. Baird & Co. with a focus on life sciences companies. Prior to Baird, Mr. Daws was the Chief Financial Officer of Concert Pharmaceuticals, Inc. Prior to that, Mr. Daws was a life-science-focused investment banker at Stifel, Nicolaus and Cowen. Mr. Daws holds a B.S. in finance and an international MBA from The Moore School of Business at the University of South Carolina.